What were we asked to look at?
The Scottish Health Technologies Group (SHTG) was asked to evaluate the evidence on clinical effectiveness, safety, and staff and patient experience of store-and-forward teledermatology for triage of primary care referrals to secondary care dermatology services.
Why is this important?
There is a urgent need to identify and fast track referrals relating to potential skin cancers in the context of lengthy wait times for dermatology, which have been exacerbated by the COVID-19 protection measures. Current practice is for the GP to submit a referral and indicate the level of urgency based on their clinical opinion.
Around 12% of primary care consultations concern skin disease and skin problems are the most common reason for a new presentation. Whilst it covers all areas of dermatology, the importance of this topic is directed by the need for patients with skin cancers to access rapid diagnosis and potentially life-saving treatment.
The National Innovation Programme Manager, Accelerated National Innovation Adoption (ANIA) Pathway, Centre for Sustainable Delivery on behalf of ANIA Collaborative, Dermatology AI Consortium and the Dermatology Clinical specialty group.